ACCORD News

ACCORD News

GDPR: Important Information For Your Clinical Research

The General Data Protection Regulation (GDPR) was implemented on 25 May 2018, together with a new Data Protection Act.

Single electronic submissions of the IRAS Form for studies led from Northern Ireland, Scotland and Wales

Update to IRAS, the Integrated Research Application System, will introduce a single, e-submission of IRAS Forms and associated documents.  

Bursaries for patient and public involvement in research

ACCORD: Bursaries for patient and public involvement in research

MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others

MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others.

MHRA Recall of Gadolinium-containing contrast agents

A class 2 medicine recall – action within 48 hours – has now been issued by the MHRA for Magnevist (Bayer plc) and Omniscan Solution (GE Healthcare).

Changes to IRAS from 18 October 2017

Changes to IRAS from 18 October 2017

Changes to IRAS from 28 June 2017

Changes to IRAS - Effective June 28th 2017

MHRA Statement on Lab Inspections

Statement from the MHRA on inspections of Labs analysing human samples as part of a clinical trial.

ACCORD Brochure

The 2017 ACCORD brochure can be found HERE